T. Rowe Price Associates
NHC icon

T. Rowe Price Associates’s National Healthcare NHC Stock Holding History

T. Rowe Price Associates’s Portfolio NHC Stock Details NHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.77M Buy
11,114
+1,711
+18% +$263K ﹤0.01% 1879
2025
Q4 		$1.29M Buy
9,403
+580
+7% +$74.9K ﹤0.01% 1969
2025
Q3 		$1.07M Buy
8,823
+675
+8% +$72.8K ﹤0.01% 2029
2025
Q2 		$872K Buy
8,148
+819
+11% +$81.9K ﹤0.01% 2048
2025
Q1 		$681K Buy
7,329
+391
+6% +$37.9K ﹤0.01% 2135
2024
Q4 		$747K Buy
6,938
+953
+16% +$116K ﹤0.01% 2101
2024
Q3 		$753K Buy
5,985
+109
+2% +$13.7K ﹤0.01% 2080
2024
Q2 		$637K Sell
5,876
-1,697
-22% -$165K ﹤0.01% 2091
2024
Q1 		$716K Buy
7,573
+439
+6% +$41.6K ﹤0.01% 2057
2023
Q4 		$660K Buy
7,134
+319
+5% +$24.4K ﹤0.01% 2056
2023
Q3 		$437K Buy
6,815
+280
+4% +$17.9K ﹤0.01% 2174
2023
Q2 		$404K Buy
6,535
+1,565
+31% +$92.8K ﹤0.01% 2230
2023
Q1 		$289K Sell
4,970
-2,337
-32% -$134K ﹤0.01% 2362
2022
Q4 		$435K Buy
7,307
+2,584
+55% +$157K ﹤0.01% 2194
2022
Q3 		$300K Sell
4,723
-1,773
-27% -$123K ﹤0.01% 2382
2022
Q2 		$454K Buy
6,496
+668
+11% +$46.8K ﹤0.01% 2257
2022
Q1 		$409K Buy
5,828
+272
+5% +$18.3K ﹤0.01% 2433
2021
Q4 		$377K Buy
5,556
+1,178
+27% +$81.5K ﹤0.01% 2513
2021
Q3 		$306K Hold
4,378
– – ﹤0.01% 2574
2021
Q2 		$306K Buy
4,378
+277
+7% +$20.1K ﹤0.01% 2594
2021
Q1 		$320K Sell
4,101
-46
-1% -$3.25K ﹤0.01% 2546
2020
Q4 		$275K Buy
+4,147
New +$273K ﹤0.01% 2453
2020
Q2 		– Sell
-10,629
Closed -$762K – 2527
2020
Q1 		$762K Buy
10,629
+57
+0.5% +$4.51K ﹤0.01% 1815
2019
Q4 		$914K Sell
10,572
-2,415
-19% -$202K ﹤0.01% 1923
2019
Q3 		$1.06M Sell
12,987
-3,644
-22% -$302K ﹤0.01% 1797
2019
Q2 		$1.35M Sell
16,631
-31,073
-65% -$2.4M ﹤0.01% 1720
2019
Q1 		$3.62M Buy
47,704
+41
+0.1% +$3.25K ﹤0.01% 1444
2018
Q4 		$3.74M Buy
47,663
+22
+0% +$1.72K ﹤0.01% 1436
2018
Q3 		$3.59M Buy
47,641
+71
+0.1% +$5.22K ﹤0.01% 1497
2018
Q2 		$3.35M Buy
47,570
+16
+0% +$1.05K ﹤0.01% 1486
2018
Q1 		$2.84M Buy
47,554
+2,022
+4% +$124K ﹤0.01% 1502
2017
Q4 		$2.77M Sell
45,532
-146,798
-76% -$9.37M ﹤0.01% 1513
2017
Q3 		$12M Sell
192,330
-184,883
-49% -$11.9M ﹤0.01% 1311
2017
Q2 		$26.5M Sell
377,213
-104,476
-22% -$7.46M ﹤0.01% 1069
2017
Q1 		$34.3M Sell
481,689
-17,190
-3% -$1.27M 0.01% 940
2016
Q4 		$37.8M Sell
498,879
-40,280
-7% -$2.79M 0.01% 912
2016
Q3 		$35.6M Sell
539,159
-59,670
-10% -$3.87M 0.01% 924
2016
Q2 		$38.8M Sell
598,829
-21,700
-3% -$1.38M 0.01% 877
2016
Q1 		$38.7M Sell
620,529
-5,300
-0.8% -$330K 0.01% 868
2015
Q4 		$38.6M Sell
625,829
-45,258
-7% -$2.93M 0.01% 858
2015
Q3 		$40.9M Sell
671,087
-136,090
-17% -$8.52M 0.01% 843
2015
Q2 		$52.5M Sell
807,177
-7,520
-0.9% -$477K 0.01% 823
2015
Q1 		$51.9M Sell
814,697
-8,220
-1% -$522K 0.01% 832
2014
Q4 		$51.7M Sell
822,917
-8,050
-1% -$484K 0.01% 824
2014
Q3 		$46.1M Sell
830,967
-10,900
-1% -$616K 0.01% 858
2014
Q2 		$47.4M Buy
841,867
+3,400
+0.4% +$185K 0.01% 881
2014
Q1 		$46.8M Buy
838,467
+4,500
+0.5% +$236K 0.01% 882
2013
Q4 		$45M Buy
833,967
+6,080
+0.7% +$311K 0.01% 879
2013
Q3 		$39.1M Buy
827,887
+17,900
+2% +$855K 0.01% 909
2013
Q2 		$38.7M Buy
+809,987
New +$37.8M 0.01% 868

Other funds holding NHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MSIIA
Morgan Stanley Institutional Investment Advisors Greenwood Village, Colorado $1.04B AUM 22.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates's NHC Position: Q1 2026 in Review

T. Rowe Price Associates increased its National Healthcare (NHC) stake by 18% in Q1 2026, buying an estimated $263K and bringing the position to 11,114 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1879.

T. Rowe Price Associates first reported a position in NHC in Q2 2013 and has held it in 50 quarters since. The position peaked at $52.5M in Q2 2015. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • T. Rowe Price Associates held 11,114 shares of National Healthcare worth $1.77M as of Q1 2026.
  • T. Rowe Price Associates bought 1,711 National Healthcare shares in Q1 2026, an estimated $263K.
  • National Healthcare made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1879 holding.
  • T. Rowe Price Associates first reported a position in National Healthcare in Q2 2013 and has held it in 50 quarters since.
  • T. Rowe Price Associates's National Healthcare position peaked at $52.5M in Q2 2015.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.